France Medical Devices Market 2022-2027
  • CHOOSE LICENCE TYPE
Consulting Services
    How will you benefit from our consulting services ?

France Medical Devices Market 2022-2027

Last Updated:  Apr 25, 2025 | Study Period: 2022-2027

FRANCE MEDICAL DEVICES MARKET

 

INTRODUCTION

 

The medical equipment market in France is thriving. Manufacturing companies will find that their products are well received if they produce in-demand technologies like diagnostic imaging equipment, disposable medical products, non-invasive surgical devices, orthopedic implants, intensive care equipment, hygiene products, and other cutting-edge products. 

 

Infographic ; France Medical Devices Market, France Medical Devices Market Size, France Medical Devices Market Trends, France Medical Devices Market Forecast, France Medical Devices Market Risks, France Medical Devices Market Report, France Medical Devices Market Share

 

Previously, French manufacturers dominated the local medical device market, but as manufacturing has shifted to other regions of the world, the market now depends more and more on imports. The future direction of the French medical device market is difficult to foresee.

 

FRANCE MEDICAL DEVICES MARKET SIZE AND FORECAST

 

The France Medical Devices market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2022 to 2027.

 

MARKET DYNAMICS

 

A number of businesses displaying ground-breaking goods and the most recent technologies were hosted at the French Pavilion, which was organized by Business France under the French Healthcare umbrella.

 

One such business is WEMED, which develops and manufactures economical, efficient, and interoperable linked medical equipment like stethoscopes. Nearly all telemedicine platforms, as well as WhatsApp, Zoom, and other platforms, are compatible with the business. 

 

Given the growing need for remote diagnostic medical equipment, the French firm has distinguished itself during the COVID-19 crisis by adjusting its products. Studies are now being conducted to determine whether pregnant women may use a stethoscope to hear their unborn child's heartbeat and the carotid artery in their neck.

 

The business is also creating a custom app that will use augmented reality. For instance, the app will be able to direct a patient who may not be aware of the precise location where the stethoscope should be put on the chest. 

 

The French National Agency for the Safety of Medicines and Health Products has given Cardiawave SA permission to move forward with a new clinical study in France.

 

Cardiawave SA is a deeptech medical device manufacturer that has created VALVOSOFT, a revolutionary non-invasive medical device to treat aortic stenosis, the most common heart valve disease in adults.

 

In addition to treating the most vulnerable patients for whom TAVI is not an option, VALVOSOFT provides a ground-breaking non-invasive therapeutic alternative that, over time, will also pave the way for new patients with calcified aortic stenosis.

 

The platform formerly known as Diabnext has been renamed Glooko XT as a result of the acquisition. Diabetes patients in France will have access to it as well as the current Glooko platform, which was created in collaboration with Novo Nordisk.

 

Glooko will also continue to provide support for people who already use the Diabnext app. The Paris-based staff of Diabnext has been assimilated into Glooko's workforce.

 

COMPANY PROFILE

 

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

  1. What is the average cost perFrance Medical Devices marketright now and how will it change in next 5-6 years?
  2. Average cost to set up aMedical Devices marketinFrance?
  3. How manyFrance Medical Devices marketare manufactured per annum globally? Who are the sub-component suppliers in different regions?
  4. What is happening in the overall public, globally?
  5. Cost breakup of aFrance Medical Devices marketand key vendor selection criteria
  6. Where is theFrance Medical Devices marketmanufactured? What is the average margin per equipment?
  7. Market share ofFrance Medical Devices marketmanufacturers and their upcoming products
  8. The most important plannedFrance Medical Devices marketin next 2 years
  9. Details on network of majorFrance Medical Devices marketand pricing plans
  10. Cost advantage for OEMs who manufactureFrance Medical Devices marketin-house
  11. 5 key predictions for next 5 years inFrance Medical Devices market
  12. Average B-2-BFrance Medical Devices marketprice in all segments
  13. Latest trends inFrance Medical Devices market, by every market segment
  14. The market size (both volume and value) ofFrance Medical Devices marketin 2022-2027 and every year in between?
  15. Global production breakup ofFrance Medical Devices market, by suppliers and their OEM relationship
Sl noTopic
1Market Segmentation
2Scope of the report
3Abbreviations
4Research Methodology
5Executive Summary
6Introduction
7Insights from Industry stakeholders
8Cost breakdown of Product by sub-components and average profit margin
9Disruptive innovation in the Industry
10Technology trends in the Industry
11Consumer trends in the industry
12Recent Production Milestones
13Component Manufacturing in US, EU and China
14COVID-19 impact on overall market
15COVID-19 impact on Production of components
16COVID-19 impact on Point of sale
17Market Segmentation, Dynamics and Forecast by Geography, 2022-2027
18Market Segmentation, Dynamics and Forecast by Product Type, 2022-2027
19Market Segmentation, Dynamics and Forecast by Application, 2022-2027
20Market Segmentation, Dynamics and Forecast by End use, 2022-2027
21Product installation rate by OEM, 2022
22Incline/Decline in Average B-2-B selling price in past 5 years
23Competition from substitute products
24Gross margin and average profitability of suppliers
25New product development in past 12 months
26M&A in past 12 months
27Growth strategy of leading players
28Market share of vendors, 2022
29Company Profiles
30Unmet needs and opportunity for new suppliers
31Conclusion
32Appendix